COVID Fraud Scams Needs to be Reported More by Whistleblowers
COVID Fraud on the Rise From March 2020 through January 13, 2023, at least 1,044 individuals pleaded guilty or were convicted of defrauding COVID-19 relief
Congress Increases Incentives for Whistleblowers Reporting Violations of the Anti-Money Laundering Act
Incentives for Whistleblowers The Department of Justice announced that INSYS Therapeutics, Inc. (“INSYS”) has agreed to pay $225 million to resolve allegations that it paid
SEC Increases Tough Scrutiny and Massive Enforcement of ESG Related Disclosures
SEC and ESG Over the past several years, investor interest has increased significantly for products and financial services that focus on environmental, social, and governance (“ESG”)
SEC Issues Impressive $220 Million in Whistleblower Awards in 2022
The Securities and Exchange Commission (SEC) recently announced that fiscal year (FY) 2022 was the second highest in both the number and dollar amount of
The CFTC Encourages Whistleblowers to Report Information Involving Commodities Fraud
The Commodity Futures Trading Commission (“CFTC” or “Commission”) may not be as familiar as it’s more well known counterpart, the Securities and Exchange Commission, but
TEVA Agrees to Pay $54 Million to Settle McEldrew Young False Claims Act Qui Tam Whistleblower Lawsuit
A $54 Million Settlement Attorney Eric. L. Young announced today that Teva Pharmaceuticals USA, Inc., Teva Neuroscience, Inc., and Teva Sales and Marketing, Inc. (hereinafter
Retina Institute Settles with Government for $6.65 Million Over Allegations of False Claims Act Violations
On October 2, 2019, Retina Institute of California Medical Group (RIC), along with its former CEO and several physicians, agreed to pay $6.65 million to resolve
DOJ Aggressively Pursues Astounding Health Care Fraud in 2019
In the first half of 2019, the United States Department of Justice (“DOJ”) has shown that it intends to aggressively pursue health care providers who
Young Law Group Whistleblower Lawsuit Against INSYS Results in $225 Million Settlement of Allegations Involving Opioid Sales and Marketing Abuses
INSYS Agrees to Global Resolution of Claims Arising from Separate DOJ Criminal and Civil Investigations The Department of Justice announced that INSYS Therapeutics, Inc. (“INSYS”)
The DNA of Medicare Fraud & the False Claims Act
Genetic Testing Laboratory Pays $2 Million to Settle Allegations of Medicare Fraud The Justice Department announced a settlement last month with GenomeDx Biosciences Corp. (“GenomeDx”), a genetic
Alleged Nationwide Kickback Scheme by Teva Pharmaceuticals Heads to Trial
Young Law Group, Philadelphia, PA. Chief U.S. District Judge Colleen McMahon ruled on February 27th that a False Claims Act suit brought by two former
The Hefty High Price of Attempted Whistleblower Retaliation
It is critical that whistleblowers are able to speak up anonymously and without fear of retaliation if they want to raise concerns. Barclays fined $15 Million for
5G Cancer Risks: Asbestos of a New Generation?
5G implementation is proceeding straightaway despite serious concerns raised by numerous credible researchers and scientists. The next generation of cell phone technology could pose serious
Pharmacy and Drug Fraud: A Prescription for Imprisonment and Big Fines
Drug Fraud Since 2018 A number of civil settlements and criminal convictions involving pharmacy and drug fraud in 2018 have highlighted a longstanding problem that
Greater Incentives for Customs Fraud Created by New High Tariffs
Setting the Stage for Customs Fraud Domestic importers are paying record amounts in customs duties due to a recent surge in the number of new
Electronic Health Records: A Prognosis for Severe Missteps and Potential Fraud
The Wall Street Journal recently reported that the Department of Veterans Affairs is in discussions with Apple to provide portable electronic health records (“EHRs”) to military
Sobering News of Surging Fraud in the Addiction Treatment Industry
The opioid epidemic has exacted an immeasurable cost on our country in both human and financial costs. It has also given rise to a new
Do Drug and Healthcare Ads Push Ethical Boundaries?
In the past four years, pharmaceutical companies have more than doubled their healthcare ad spending, making it the second-fastest growing ad category in the nation.